Brief: Biosynex Says It Holds 18.82% Of Theradiag Capital

Theradiag SA

29/11/2021 07:05

Nov 29 (Reuters) - BIOSYNEX SA  ALBIO.PA :
    * SAYS IT HOLDS 18.82% OF THE CAPITAL OF THERADIAG

Source text for Eikon:  ID:nEQ1fSYpma 
Further company coverage:  ALBIO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))